+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celldex Therapeutics, Inc. - logo

Celldex Therapeutics is a biopharmaceutical company that develops, manufactures, and commercializes novel therapeutics for human health care. The company's pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines. The company's lead drug candidates are Rintega, Glembatumumab vedotin, Varlilumab and others. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex. It is now headquartered in Hampton, New Jersey.

Global HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Forecast 2023-2030 - Product Thumbnail Image

Global HIV Vaccines Market by Antibodies (Dicloxacillin, Fusidic Acid Ointment, Gentamicin Ointment), Type (Acute Paronychia, Candidal Paronychia, Chronic Paronychia), Category - Forecast 2023-2030

  • Report
  • October 2023
  • 185 Pages
  • Global
From
Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates) - Product Thumbnail Image

Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical Trial Analysis, Clinical Publications Analysis, and Estimated Time to Market Analysis for Novel Drug Candidates)

  • Report
  • February 2022
  • 84 Pages
  • Global
From
Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 - Product Thumbnail Image

Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

  • Report
  • April 2020
  • 536 Pages
  • Global
From
Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026 - Product Thumbnail Image

Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026

  • Report
  • October 2019
  • 170 Pages
  • Global
From
Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

  • Report
  • May 2023
  • 391 Pages
  • Global
From
Chronic Urticaria or Hives Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Urticaria or Hives Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • July 2022
  • 118 Pages
  • Global
From
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 100 Pages
  • Global
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028 - Product Thumbnail Image

Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028

  • Report
  • February 2022
  • 800 Pages
  • Global
From
Global Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Forecast 2023-2030 - Product Thumbnail Image

Global Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Forecast 2023-2030

  • Report
  • October 2023
  • 197 Pages
  • Global
From
Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020 - Product Thumbnail Image

Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1285 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • May 2022
  • 180 Pages
  • Global
From
Liver Cancer - Pipeline Insight, 2022 - Product Thumbnail Image

Liver Cancer - Pipeline Insight, 2022

  • Clinical Trials
  • June 2022
  • 210 Pages
  • Global
From
Brain Hemorrhage - Pipeline Insight, 2020 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2020

  • Clinical Trials
  • February 2020
  • 106 Pages
  • Global
From
Global Immunotherapy Drugs Market 2024-2028 - Product Thumbnail Image

Global Immunotherapy Drugs Market 2024-2028

  • Report
  • November 2023
  • 163 Pages
  • Global
From
2019 Ocular Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Ocular Melanoma Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 60 Pages
  • Global
From
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 322 Pages
  • Global
From
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 1560 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 507 Pages
  • Global
From
Monoclonal Antibodies (MAbS) Global Market Report 2023 - Product Thumbnail Image

Monoclonal Antibodies (MAbS) Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Loading Indicator